U.S Vaccine Market to Exhibit 4.3% Cagr, Driven by Favorable Government Initiatives

Submitted by: Submitted by

Views: 10

Words: 2150

Pages: 9

Category: Business and Industry

Date Submitted: 12/08/2015 05:03 AM

Report This Essay

Transparency Market

Research

U.S. Vaccine Market - Industry Analysis, Size, Share, Growth, Trends and Forecast

2014 - 2020

Published Date

27-Jan-2015

83 Page Report

Buy Now

Request Sample

Press Release

U.S Vaccine Market to Exhibit 4.3% CAGR, Driven by Favorable

Government Initiatives:Transparency Market Research

Transparency Market Research

State Tower,

90, State Street, Suite 700.

Albany, NY 12207

United States

www.transparencymarketresearch.com

sales@transparencymarketresearch.com

U.S. Vaccine Market

REPORT DESCRIPTION

U.S. Vaccine Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

A vaccine is a biological preparation of killed forms of microbes, living attenuated organisms, living fully virulent

organisms, a microbe’s toxins or one of its surface proteins. Vaccines play a key role in improving immunity against

particular diseases. Therefore, vaccination is promoted as a vital public health intervention throughout the globe.

According to the World Health Organization (WHO), vaccination has reduced the burden of infectious disease globally to a

great extent. According to a study conducted by Zhou et al, vaccination prevented 42,000 early deaths and approximately

20 million cases of diseases in children born in the U.S. in 2009, resulting in saving USD 13.5 billion in direct medical and

non-medical costs and USD 68.8 billion in total societal costs.

Browse the full report at

http://www.transparencymarketresearch.com/us-vaccine-market.html

This report on the U.S. vaccine market offers an insightful and in-depth assessment of the current as well as future market

potential of human as well as animal vaccine markets. The human vaccine market is further segmented into pediatric and

adult vaccine markets, based on vaccine type. On the basis of different antigens, the U.S. human vaccine market has

been categorized into hepatitis, influenza, meningococcal, pneumococcal, human...